Cases & Deals

EDBI invests in Tessa Therapeutics

Clients EDBI Pte Ltd

Jones Day represented EDBI Pte. Ltd. in connection with its affiliate's purchase of stock in a private placement by Tessa Therapeutics Pte. Ltd., an international clinical stage biopharmaceutical company focusing on T cell therapy for solid tumors. Temasek, Karst Peak Capital, Heliconia Capital Management, and Heritas acted as co-investors in the $80 million investment round.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.